Zhou Jintuo, Zhu Yanting, Liu Ying, Zhan Hairong, Niu Peiguang, Chen Huajiao, Zhang Jinhua
Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Res Pract Thromb Haemost. 2024 Aug 5;8(6):102541. doi: 10.1016/j.rpth.2024.102541. eCollection 2024 Aug.
Hospital-acquired venous thromboembolism (HA-VTE) in children has been widely regarded.
We aimed to analyze the proportion and risk factors for HA-VTE in hospitalized children.
We conducted a comprehensive systematic search across 4 databases from 1990 to 2023. Cochran Q test was used to evaluate the heterogeneity of the effect sizes of study, and I statistic was used to quantify the heterogeneity. Pooled estimates were calculated by the inverse-variance weighted method in a fixed-effect model or a random-effect model when heterogeneity was low (I < 25%) or high (I > 25%), respectively.
In total, 105 original papers and 20,718,294 patients were included in the study, and the proportion of HA-VTE in children was 4.1% (95% CI, 2.9%-5.2%). Although the proportion of venous thromboembolism increased over the various research periods, the differences were not statistically significant. In the subgroup analysis based on country, the proportion of pediatric HA-VTE was lowest in the United Kingdom and highest in Spain, whereas when based on region, the proportion was lowest in Asia and highest in North America. Multiple HA-VTE risk factors were identified, including central venous catheter use, age of >10 years, surgery, injury, infection, obesity, mechanical ventilation, blood transfusion, malignancy, coagulation and hemorrhagic disorders, and length of hospital stay.
In this study, we systematically analyzed the proportion and risk factors of HA-VTE in hospitalized children. Our findings provide valuable insights for the prevention and treatment of HA-VTE in pediatric patients.
儿童医院获得性静脉血栓栓塞症(HA-VTE)已受到广泛关注。
我们旨在分析住院儿童HA-VTE的比例及危险因素。
我们对1990年至2023年期间的4个数据库进行了全面系统的检索。采用Cochran Q检验评估研究效应量的异质性,并用I统计量量化异质性。当异质性较低(I<25%)或较高(I>25%)时,分别采用固定效应模型或随机效应模型中的逆方差加权法计算合并估计值。
该研究共纳入105篇原始论文及20,718,294例患者,儿童HA-VTE的比例为4.1%(95%CI,2.9%-5.2%)。尽管在不同研究期间静脉血栓栓塞症的比例有所增加,但差异无统计学意义。在基于国家的亚组分析中,英国儿童HA-VTE的比例最低,西班牙最高;而基于地区的亚组分析中,亚洲的比例最低,北美最高。确定了多个HA-VTE危险因素,包括中心静脉导管使用、年龄>10岁、手术、损伤、感染、肥胖、机械通气、输血、恶性肿瘤、凝血和出血性疾病以及住院时间。
在本研究中,我们系统分析了住院儿童HA-VTE的比例及危险因素。我们的研究结果为儿科患者HA-VTE的预防和治疗提供了有价值的见解。